Roche’s Cardiometabolic Head Has Lilly and Novo In His Crosshairs

 
• By David Wild
  
Roche_Basel
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from In Vivo

More from Innovation